Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Shares Issued (2017 - 2025)

Catheter Precision (VTAK) has disclosed Shares Issued for 7 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a N/A change, with the full-year FY2023 number at $1.3 million, down 92.99% from a year prior.
  • Shares Issued was $2.2 million for Q3 2025 at Catheter Precision, up from $1.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $18.9 million in Q4 2022 to a low of -$25000.0 in Q3 2022.
  • A 4-year average of $4.2 million and a median of $813000.0 in 2021 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 39287.5% in 2022; the steepest drop was 91.67% in 2022.
  • Catheter Precision's Shares Issued stood at $48000.0 in 2021, then surged by 39287.5% to $18.9 million in 2022, then plummeted by 92.99% to $1.3 million in 2023, then soared by 63.95% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Shares Issued are $2.2 million (Q3 2025), $1.3 million (Q1 2023), and $18.9 million (Q4 2022).